Iovance Biotherapeutics
Commercializes TIL cell therapies for melanoma and other solid-tumor settings.
$8.03
After-hours close+0.00 (+0.06%)
At close$8.03(−2.85%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 60.27%269.11M sharesInsiders 0.32%1.42M sharesOther 39.41%175.98M shares
Shares outstanding 446.50M · Float 387.87M · 86.9% free float
Institutions13F, as of Mar 31, 2026
302 holders · 269.11M shares · 68 new positions · 188 increased · 58 reduced · 41 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 31.08M | 6.96% | +1.56M | May 13, 2026 |
| MHR Fund Management LLC | 28.97M | 6.49% | 0 | May 15, 2026 |
| State Street Corp | 17.45M | 3.91% | −2.71M | May 15, 2026 |
| Vanguard Capital Management LLC | 16.62M | 3.72% | +16.62Mnew | May 15, 2026 |
| Two Sigma Investments, LP | 13.69M | 3.07% | +9.29M | May 15, 2026 |
| Vanguard Portfolio Management LLC | 11.70M | 2.62% | +11.70Mnew | May 8, 2026 |
| Millennium Management LLC | 9.41M | 2.11% | +2.83M | May 15, 2026 |
| Goldman Sachs Group Inc | 8.76M | 1.96% | +152.5K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 6.40% | 21.31M | 13G | Jul 17, 2025 ↗ |
| State Street Corporation | 5.50% | 24.48M | 13G | Aug 7, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Frederick G. Vogt | director, officer: Interim CEO & General Counsel | 562.5K | 0.13% | Jun 9, 2026 |
| Raj K. Puri | officer: Chief Regulatory Officer | 248.1K | 0.06% | Jun 9, 2026 |
| Daniel Gordon Kirby | officer: Chief Commercial Officer | 154.5K | 0.03% | Aug 12, 2026 |
| Finckenstein Friedrich Graf | officer: Chief Medical Officer | 140.1K | 0.03% | Jun 9, 2026 |
| Igor Bilinsky | officer: Chief Operating Officer | 133.9K | 0.03% | Jun 9, 2026 |
| Matthew W. Rosinack | officer: SVP, Finance (Int. PFO & PAO) | 89.1K | 0.02% | Jul 10, 2025 |
| Jean-Marc Bellemin | officer: Chief Financial Officer | 60.5K | 0.01% | Jun 4, 2025 |
| Corleen M. Roche | officer: Chief Financial Officer | 28.8K | 0.01% | Aug 10, 2026 |
4 ten-percent owners hold 6.75M shares by Form 4, outside the officers-and-directors figure above · 16 people have not refiled in the last 18 months (32.27M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.